vTv Therapeutics (VTVT) Assets Average (2015 - 2026)

vTv Therapeutics' Assets Average history runs 12 years deep, the most recent figure standing at $94.4 million for Q1 2026.

• In Q1 2026, Assets Average rose 168.46% year-over-year to $94.4 million; the TTM figure through Mar 2026 stood at $94.4 million (up 168.46% YoY), while the FY2025 annual figure was $64.1 million, up 160.05% from the prior year.
• Assets Average came in at $94.4 million for Q1 2026 at vTv Therapeutics, roughly flat from $94.7 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $94.7 million in Q4 2025 to a low of $13.0 million in Q4 2023.
• A 5-year average of $40.9 million and a median of $34.4 million in 2022 frame the typical range for Assets Average.
• Across the five-year window, Assets Average plunged 62.27% in 2023 and surged 213.89% in 2024, its largest moves.
• vTv Therapeutics' Assets Average stood at $34.4 million in 2022, then slumped by 62.27% to $13.0 million in 2023, then soared by 213.89% to $40.7 million in 2024, then surged by 132.58% to $94.7 million in 2025, then decreased by 0.36% to $94.4 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $94.4 million, $94.7 million, and $63.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison